Informations générales (source: ClinicalTrials.gov)

NCT04431999 En recrutement IDF
Evaluation of a Transfusion Therapy Using Whole Blood Versus Fractionated Blood Products in the Management of Coagulopathy in Patients Admitted to Hospital for Acute Traumatic Hemorrhage (T-STORHM)
Interventional
  • Troubles de l'hémostase et de la coagulation
  • Hémorragie
  • Troubles de l'hémostase
Phase 3
Direction Centrale du Service de Santé des Armées (Voir sur ClinicalTrials)
décembre 2021
janvier 2026
05 avril 2025
The prognosis of traumatized hemorrhages is correlated with the nature of transfusion therapy: a 50% reduction in mortality for an early and massive supply of plasma, and 20% for an early and massive supply of platelets. However, this strategy encounters logistical difficulties, particularly in a context of collective emergency (attacks). The use of whole blood, widely documented by the Armed Forces, improves the availability of plasma and platelets, and simplifies handling by the various actors in the chain. T-STORHM is a randomized, controlled, parallel clinical trial.This study tests non-inferiority of whole blood transfusion therapy in the management of coagulopathy in patients with acute traumatic hemorrhage.
 Voir le détail

Etablissements

Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
AP-HP - Hôpital Bicêtre Marie WERNER En recrutement IDF Contact (sur clinicalTrials)
HIA PERCY Thibault MARTINEZ En recrutement IDF Contact (sur clinicalTrials)
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
HIA Sainte Anne - 83000 - Toulon - France Eric Meaudre En recrutement Contact (sur clinicalTrials)
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
CHU de Grenoble - 38000 - Grenoble - France Pierre BOUZAT En recrutement Contact (sur clinicalTrials)
CHU de La Cavale Blanche - Brest - 29200 - Brest - France Philippe ARIES En recrutement Contact (sur clinicalTrials)
CHU de La Pitié-Salpêtrière - 75013 - Paris - France Mathieu RAUX En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

Severe trauma patients requiring the initiation of a massive transfusion protocol
determined on

1. At least two Red flag score factors (according to pre-hospital data) :

- Suspected pelvic fracture

- Shock index (FC / PAS)> = 1

- Microdose hemoglobin <13g

- Average blood pressure <70 mmHg

- Need for prehospital tracheal intubation

2. AND at least two criteria of the Assessment of Blood Consumption (ABC) score
established at the patient's arrival:

- Penetrating trauma

- Focused Abdominal Sonography for Trauma (FAST) echo positive

- Blood pressure <90 mmHg

- Respiratory rate >120 bpm

3. AND/OR after clinical assessment and on the prediction of the practitioner in charge
of the treatment of the injured person of the need to transfuse during the emergency
management of the injured person



- Non-traumatic hemorrhage

- Patients transfused with more than two PRBCs before the initiation of the massive
transfusion protocol.

- Anti-coagulation treatment

- Pregnancy

- Age < 18 years

- Patient refusing administration of blood products

- Patient transferred from another hospital

- Patient nor transported by a physician-staffed prehospital emergency medical system

- Burn patient (≥30% of body surface).

- Patient under specific known transfusion protocol (for example : allo
immunization...)